Medpace Holdings, Inc.

MEDP Healthcare Diagnostics & Research

Medpace Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 20.0% from fiscal 2024.

Revenue
+8.50%
EPS
+24.6%
Free cash flow
−16.6%

Quarter to September 2026, against a year earlier

652.89 17.91 +2.82%
Market cap
$17.8B
P/E
34.6×
Fwd P/E
35.8×
Dividend yield
—
F-score
8/9
Altman Z
8.04
Beneish M
−2.92
Dividend safety
n/a
Sep '26 Jun '26 Mar '26 Dec '25 Older periods
Piotroski F-Score
9 9 9 8

+8 more TTM periods

ROE
117.88% 162.15% 77.25% 70.23%
ROA
25.54% 27.09% 22.87% 22.13%
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
(680.52%) (215.54%) (663.29%) (202.23%)
Average Days of Receivables
57.56 57.96 53.77 58.00
Free Cash Flow per Share
23.90 25.08 25.00 23.64
Free Cash Flow
667.63 706.69 711.00 681.87
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026